Working Group on Access to Medicines - India
@a2mindia
Followers
30
Following
1
Media
39
Statuses
85
We are a network of patients, activists and professionals fighting for affordable medicines in India.
India
Joined March 2024
We are the Working Group on Access to Medicines & Treatments - India. We will share the work we are doing as a collective nationwide to make medicines affordable–from cancer drugs to insulin pens.
0
0
2
🎥 Watch the full podcast with Dr Gopal Dabade & @singh_jyotsna to learn how the system works — and how you can benefit. ▶️ https://t.co/T1zmtMGcWF Please share widely. #AffordableMedicines #HealthForAll #PMBJK #RightToHealth
0
0
0
4/ The ideal model: ✅ Free medicines in government hospitals ✅ #JanAushadhi stores near private clinics The government must ensure consistent supply, maintain quality and scale the scheme across the country.
1
0
0
Here are examples of common medicines whose prices have dropped significantly under Jan Aushadhi: [insert graphic] 📉 These savings make a real difference when meds are needed every month.
1
0
0
The reason? No brand names — only the salt name. That means no brand premium, no marketing markup, no middle-person cuts. That’s how the cost comes down. #JanAushadhi #Health4All #Access2Medicines
1
0
0
🚨New Podcast 🎙️ Medicine prices in India are sky-high. But #JanAushadhi scheme can reduce medicine costs by as much as 75% — a game-changer for anyone who needs lifelong treatment for BP, diabetes and more. https://t.co/T1zmtMGcWF
1
0
1
🎙️ Listen to our latest podcast: Patents, Prices & Power. On this #AccessDenied episode, we welcome @johnroshanj from @MSF_SouthAsia on the hidden dangers of India’s FTAs and how we can fight back. Full episode▶️ https://t.co/pyVZZwShMF
0
3
4
Trade must serve the public, not corporate profit. We need: ✅ Transparency ✅ Parliamentary debate before signing ✅ Protection of India’s pro-public health laws
1
0
1
The result? ❌ Higher medicine prices ❌ Poorer access to treatment ❌ Millions pushed into poverty by health costs
1
0
1
They are negotiated in secrecy. The public only sees the text after it’s signed. No public debate. No parliamentary oversight.
1
0
1
These FTAs demand changes to India’s patent laws —adding more barriers and extending monopolies for Big Pharma. That means life-saving medicines stay expensive for longer.
1
0
1
🚨 Medicine prices in India are under threat. New Free Trade Agreements with developed countries could mean higher medicine prices and block affordable generics. 🧵 Here’s how 👇 #AccessDenied episode▶️ https://t.co/pyVZZwShMF
1
1
2
Breaking Barriers to SMA Treatment
0
0
0
India’s draft guidelines on biosimilar drugs can make treatments more accessible, affordable https://t.co/csJwmunBe6 via @theprintindia
theprint.in
Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.
0
0
0
India–UK Free Trade Agreement: A Response on Access to Medicines @DPIITGoI
accesstomedicinesindia.wordpress.com
The India–UK Free Trade Agreement (FTA) was on 24th July 2025. While the signing has been hailed as historic, our Working Group on Access to Medicines and Treatments believes it is urgent to highli…
0
0
0
Eliminate unnecessary animal studies, establish clear conditions for comparative clinical trials, say healthcare advocates
thehindu.com
Urgent call to eliminate animal studies and establish clear guidelines for affordable biosimilars, ensuring safety and efficacy.
0
0
0
